Delpazolid

N/A

Report date: 2022/07/04 19:38:02
NMEQIDP

Base Information

Drug NameDelpazolid
Drug Alias NameLCB01-0371RMX-2001
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Oxazolidinone antibiotics
Mechanisms of Action50S ribosomal subunit inhibitorsProtein biosynthesis inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsStaphylococcal InfectionsTuberculosis, PulmonaryTuberculosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTanzaniaSouth AfricaSouth Korea +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLegochembio
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLigaChem Biosciences IncNormax (Shanghai) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis, PulmonaryTuberculosisMycobacterium Infections, Nontuberculous
Inactive IndicationsStaphylococcal InfectionsInfections

Other Information

ATC CodeN/A
Related LinksN/A